FDA Releases Draft Guidance on Clinical Pharmacology in Pediatric Studies

Drug Industry Daily
A A
Sponsors submitting pediatric study plans for a drug have several options to determine optimal dosing for children when no standard dosing information exists, according to an FDA draft guidance on clinical pharmacology in pediatric studies.

To View This Article:

Login

Subscribe To Drug Industry Daily